Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation

BACKGROUND: The introduction of non–vitamin K antagonist oral anticoagulants has been a major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in clinical trials may not translate to routine practice. We aimed to evaluate the effectiveness and safety of dabigatran, ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Xiaoxi, Abraham, Neena S., Sangaralingham, Lindsey R., Bellolio, M. Fernanda, McBane, Robert D., Shah, Nilay D., Noseworthy, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937291/
https://www.ncbi.nlm.nih.gov/pubmed/27412905
http://dx.doi.org/10.1161/JAHA.116.003725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937291/
https://www.ncbi.nlm.nih.gov/pubmed/27412905
http://dx.doi.org/10.1161/JAHA.116.003725

Ejemplares similares